
Character Biosciences develops targeted therapies by identifying the genetic and molecular drivers of progressive polygenic diseases such as age-related macular degeneration. The company combines human genomics with longitudinal clinical records, retinal imaging, AI-enabled biomarker quantification, and machine learning to reclassify disease into genetically defined subtypes and pinpoint therapeutic targets. Character Bio operates as a precision medicine drug-discovery and development company that partners with ophthalmology clinics to build deeply phenotyped patient cohorts for research and trial enrollment. Its platform supports target discovery, patient selection, and the advancement of lead programs toward clinical trials. The approach aims to deliver more precise medicines by matching individual patients to therapies that address their specific disease drivers.

Character Biosciences develops targeted therapies by identifying the genetic and molecular drivers of progressive polygenic diseases such as age-related macular degeneration. The company combines human genomics with longitudinal clinical records, retinal imaging, AI-enabled biomarker quantification, and machine learning to reclassify disease into genetically defined subtypes and pinpoint therapeutic targets. Character Bio operates as a precision medicine drug-discovery and development company that partners with ophthalmology clinics to build deeply phenotyped patient cohorts for research and trial enrollment. Its platform supports target discovery, patient selection, and the advancement of lead programs toward clinical trials. The approach aims to deliver more precise medicines by matching individual patients to therapies that address their specific disease drivers.
About Character Biosciences Character Biosciences is a precision medicine company pioneering targeted therapies for polygenic diseases, with an initial focus on ophthalmology. Our patient data platform integrates genomics with deep, longitudinal clinical and imaging data, enabling us to uncover genetic drivers of disease progression, advance novel therapeutics, and define patient stratification strategies that improve clinical success.
Our interdisciplinary team, comprising experts in clinical science, data science, statistical genetics, computer vision, and drug discovery, utilizes this platform to determine genetic drivers of disease progression, advance novel therapeutics and define genetics-based patient stratification. Powered by our data platform, Character Bio is currently advancing two programs in Dry Age-related Macular Degeneration (AMD) with additional programs for other disease areas (e.g. Glaucoma) in earlier stages of discovery research.
Founded in 2018, Character has raised capital from leading investors at the intersection of healthcare and technology, including an oversubscribed $110+ million Series B in 2025 co-led by aMoon and Luma Group, with participation from Bausch + Lomb, Sanofi Ventures, Innovation Endeavors, Catalio Capital Management, S32, KdT Ventures, and Jefferson Life Sciences. We also maintain a multi-target drug discovery collaboration with Bausch + Lomb to develop innovative precision medicines for AMD.
Role : Associate Director/Director, Network and Provider Engagement
Reports to: Head, Clinical Network & Longitudinal Research
Department: Clinical Research
Team: Observational Research
Level: Associate Director / Director
Location : Jersey City, NJ
The Opportunity As our Associate Director/Director, Network & Provider Engagement, you will own the strategy and management of Character Bio’s research provider network. You will be accountable for building, expanding, and optimizing relationships with clinical sites, providers, key opinion leaders, healthcare systems, and academic partners to meet the company’s research and scalability goals. This role leads all aspects of network operations - including performance targets, partner satisfaction, budget oversight, contracting, operational efficiency, and the development and execution of scalable processes that support multi-site research activities.
You will work both independently and cross-functionally, collaborating with teams in operations, data, clinical development, data science, and corporate strategy. You will identify and resolve complex operational and logistical challenges, drive continuous process improvement, and an escalation point for provider and site issues that go beyond individual studies/trials. As a leader, you will represent the provider network in strategic planning and internal discussions and have significant input into the direction of Character Bio’s broader research execution capabilities.
This is a hybrid role based at our headquarters in Jersey City, NJ. Remote work may be considered. Key Responsibilities
Relationship Management & Senior Partner Engagement
Operational Leadership & Process Innovation
Cross-Functional & Strategic Stakeholder Leadership
Skills And Qualifications
Preferred Qualifications
Compensation & Benefits The annual pay range for this full-time position is $170,000-$200,000 + equity + benefits
This salary range represents the expected base compensation for this role and may vary based on factors including experience, skills, and level.
Benefits include a competitive salary, strong equity incentives, medical, dental, vision, 401(k), an accrued paid time off policy. Character is committed to recruiting, developing, and supporting colleagues from all backgrounds. We embrace diversity, equity, and inclusion as an integral part of our culture.
EEO Statement Character Biosciences is an equal opportunity employer and is committed to building a diverse and inclusive workforce. We do not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other legally protected status.
Work Authorization Applicants must be authorized to work in the United States.